331A — Medix Cashflow Statement
0.000.00%
- ¥4bn
- ¥680m
- ¥4bn
Annual cashflow statement for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | JAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 637 | 788 | 952 |
| Depreciation | |||
| Non-Cash Items | 147 | -30.6 | -131 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -297 | -123 | -366 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 558 | 676 | 500 |
| Capital Expenditures | -44.8 | -44.1 | -17.2 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 73.4 | 52.6 | 432 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 28.7 | 8.51 | 414 |
| Financing Cash Flow Items | -28 | -45.5 | -0.001 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -0.544 | -218 | 76.3 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 586 | 467 | 991 |